Editorial: Resistance to Endocrine Therapies in Cancer

被引：1

作者：

Ranganathan, Prathibha ^{[1
]}

Chakrabarty, Anindita ^{[2
]}

Hiscox, Stephen ^{[3
]}

Limaye, Anil Mukund ^{[4
]}

Vella, Veronica ^{[5
]}

机构：

[1] Ctr Human Genet, Bengaluru, India

[2] Shiv Nadar Univ, Dept Life Sci, Greater Noida, India

[3] Cardiff Univ, Sch Pharm & Pharmaceut Sci, Cardiff, Wales

[4] Indian Inst Technol Guwahati, Dept Biosci & Bioengn, Gauhati, India

[5] Univ Catania, Garibaldi Nesima Hosp, Dept Clin & Expt Med, Catania, Italy

来源：

FRONTIERS IN ENDOCRINOLOGY | 2020年 / 11卷

关键词：

endocrine therapy; growth factor signaling; tumor microenvironment; non-canonical signaling; drug resistance; hormone ablation; estrogen receptor;

D O I：

10.3389/fendo.2020.00196

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：2